Drug Shortage Report for SANDOZ ATORVASTATIN

Last updated on 2017-10-25 History
Report ID 21261
Drug Identification Number 02324970
Brand name SANDOZ ATORVASTATIN
Common or Proper name ATORVASTATIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-09-01
Estimated end date 2017-09-22
Actual end date 2017-09-22
Shortage status Resolved
Updated date 2017-10-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-10-25 French Compare
v6 2017-10-25 English Compare
v5 2017-09-07 French Compare
v4 2017-09-07 English Compare
v3 2017-09-07 English Compare
v2 2017-09-07 English Compare
v1 2017-09-07 English Compare

Showing 1 to 7 of 7